Ensuring the timely mass vaccination of the population
23.2.2021
Question for written answer E-001058/2021
to the Commission
Rule 138
Dimitrios Papadimoulis (The Left), Ernest Urtasun (Verts/ALE), Raphaël Glucksmann (S&D), Rasmus Andresen (Verts/ALE), David Cormand (Verts/ALE), Alexis Georgoulis (The Left), Aurore Lalucq (S&D), Elena Kountoura (The Left), Petros Kokkalis (The Left), Konstantinos Arvanitis (The Left), Dietmar Köster (S&D), Gabriele Bischoff (S&D), Stelios Kouloglou (The Left), Martin Schirdewan (The Left)
On 19 January, the Commission called on the Member States to accelerate vaccinations across the EU and to vaccinate at least 70 % of the adult population by summer 2021[1]. It has been reported, however, that the vaccine roll-out in the EU should be happening five times faster if this target is to met[2]. On the contrary, there have been some serious cases of non-compliance with vaccine development and delivery schedules which are undermining the timely mass vaccination of the population.
Joining the voices of the World Health Assembly[3], India and South Africa[4], UN human rights experts[5] and civil society initiatives[6], the Parliamentary Assembly of the Council of Europe has urged the Member States and the EU to ‘overcome the barriers and restrictions arising from patents and intellectual property rights, in order to ensure the widespread production and distribution of vaccines in all countries and to all citizens’[7].
- 1.What concrete measures will the Commission take to ensure the timely mass vaccination of the population in order to achieve the goal it has set?
- 2.Can the Commission confirm estimates that the EU vaccine roll-out should be happening five times faster if the 70 % target is to be met?
- 3.Given the serious delays and the possibility of an impasse, is the Commission willing to take effective measures to overcome the barriers and restrictions arising from patents and intellectual property rights?
- [1] https://ec.europa.eu/info/sites/info/files/communication-united-front-beat-covid-19_en.pdf
- [2] https://www.politico.eu/article/coronavirus-vaccine-europe-hit-commission-target-rollout-5-times-faster/
- [3] https://apps.who.int/gb/ebwha/pdf_files/WHA73/A73_R1-en.pdf
- [4] https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=q:/IP/C/W669.pdf&Open=True
- [5] https://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=26484&LangID=E
- [6] https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1499
- [7] Resolution 2361 (2021) of 27 January 2021, ‘Covid-19 vaccines: ethical, legal and practical considerations’, point 7.1.7, https://pace.coe.int/pdf/2e0ee40b5d6c4e2e5df5467478961f7561e651733326667a8259ffe25682ae848428feba12/resolution%202361.pdf